# MedFocus Funds

MedFocus Funds is a Private Equity based in Irvine, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Irvine, United States
- **Region:** North America
- **Address:** 30 Fairbanks Ste. 100, Irvine, California 92618, United States
- **Founded:** 2000
- **Assets under management:** Undisclosed
- **Website:** www.medfocusfunds.com
- **LinkedIn:** linkedin.com/company/medfocus

## Regulatory record

- **Reports private funds:** No

## About

MedFocus is a medical device private equity and incubator venture capital firm that nurtures and grows emerging medical device companies. Since 2000 it has been on the leading edge of medical device research and emerging technology. It has invested in 35 companies with 21 acquisitions, and a number of these firms were founded and incubated by MedFocus based on advanced therapies for cardiovascular, neurovascular and orthopedic diseases.

## Sectors

- Medical Devices

## People

- Michael Henson — Founder
- Ed Roschak — Principal
- Tracy Person — Co-Founder, Member
- Maria Nevarez — Operations Manager, Member

## Questions

### Who runs investment decisions at MedFocus Funds?

Founder Michael Henson drives sourcing and investment committee decisions, supported by principal Ed Roschak. Henson draws on experience founding more than twenty medical-technology firms and chairing six IPOs. Roschak, a named inventor on over 40 patents, contributes technical due diligence and operational leadership.

### How does MedFocus source proprietary deal flow?

MedFocus builds companies from physician-and-engineer networks that surface unmet clinical needs in cardiovascular, neurovascular, and orthopedic disease. The firm does not run a traditional scout program — it relies on Henson's three-decade Rolodex and Roschak's relationships from senior roles at Hewlett-Packard, Origin Medsystems, and Boston Scientific-acquired ventures.

### What investment stages does MedFocus typically target?

MedFocus targets the earliest stage of device innovation — often pre-revenue, concept-stage companies it incubates internally. The firm builds management, handles regulatory groundwork, and seeks a trade sale or IPO path rather than participating in growth-stage or buyout rounds.

### What is MedFocus's known posture on co-investments alongside external GPs?

The public record does not detail a co-investment program. MedFocus's historical deals — including the Integra LifeSciences acquisition of Rebound Therapeutics and Orthopediatrics' purchase of ApiFix — were full acquisitions of incubated companies rather than syndicated venture rounds.

### What is the MedFocus management company's relationship to its portfolio?

The management company serves as corporate officer for several portfolio firms, handling governance, risk management, contract management, and human resources. This centralization allows the incubator to reduce administrative burn for scientific founders while retaining operational control.

## Related profiles

- [MED-FINE Capital](https://altss.com/profile/med-fine-capital)
- [Medholdings Capital](https://altss.com/profile/medholdings-capital)

---

Last updated: 2026-08-11T15:07:26.757Z

Canonical page: https://altss.com/profile/medfocus-funds

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology